As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.
Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer.
The U.S. Department of Health and Human Services (HHS) posted the COVID-19 Testing Plans from all states and localities for July through December on its website.
MEMPHIS, Tenn. (AP) — When Claudia Guzman suspected she had caught the coronavirus, her friends and family were full of advice: Don’t quarantine. Don’t get tested. A homemade tea will help cure you.
Recent Comments